Brief: Miromatrix Reports First Quarter 2023 Results And Provides Corporate Update
11/05/2023 21:43
May 11 (Reuters) - Miromatrix Medical Inc MIRO.O :
* MIROMATRIX REPORTS FIRST QUARTER 2023 RESULTS AND PROVIDES
CORPORATE UPDATE
* MIROMATRIX MEDICAL INC - CONFIRMED PLANS TO SUBMIT A
RESPONSE TO
FDA CLINICAL HOLD LETTER PERTAINING TO MIROLIVERELAP IN SECOND
HALF OF 2023
* MIROMATRIX MEDICAL INC - QTRLY LOSS PER SHARE $0.33
Source text for Eikon: ID:nGNXbQSfcz
Further company coverage: MIRO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Miromatrix Medical
See all newsU.S. STOCKS ON THE MOVE-SeaStar, SJW Group, Pinterest
U.S. STOCKS ON THE MOVE-Crypto, Miromatrix Medical, US banks
U.S. STOCKS ON THE MOVE-JinkoSolar, Reviva, MeiraGTx
U.S. STOCKS ON THE MOVE-McDonald, Coherus BioSciences, Miromatrix,
Brief: Miromatrix To Pay United Therapeutics Termination Fee Of $4 Million In Connection With Termination Of Merger